CellWell record HH-373181
Dihydroartemisinin alleviates ulcerative colitis by modulating gut microbiota and butyrate to restore Treg/Th17 balance and intestinal barrier function.
Qingjie Fan; Han Lu; Xiaochen Chi; Guang-Jing Liu; Yu-Jia Dong; Peng Zhang; Xiaokun Shen; Gao-Fu Fan
International Immunopharmacology ยท 2026
In plain language
Dihydroartemisinin ameliorated experimental ulcerative colitis dose-dependently by promoting butyrate-producing bacteria, restoring regulatory T cell balance, and reinforcing intestinal barrier function.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-373181
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.